We interviewed GraniteShares' CEO Will Rhind from New York, soon after they launched a suite of ETP's which allow you to invest in three different baskets of giant US tech stocks. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Study finds AstraZeneca's COVID-19 vaccine follows genetic instructions

Thu, 22nd Oct 2020 11:05

LONDON, Oct 22 (Reuters) - AstraZeneca's Oxford
COVID-19 vaccine accurately follows the genetic instructions
programmed into it by its developers to successfully provoke a
strong immune response, according to a detailed analysis carried
out by independent scientists.

"The vaccine is doing everything we expected and that is
only good news in our fight against the illness," said David
Matthews, an expert in virology from Bristol University, who led
the research.

(Reporting by Sarah Young and Kate Kelland, editing by Alistair
Smout)

Related Shares

More News

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

4 May 21 15:50

AstraZeneca's Forxiga gets US approval for chronic kidney disease

(Sharecast News) - AstraZeneca said on Tuesday that Farxiga has been approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes.

4 May 21 07:23

AstraZeneca hails progress on chronic kidney disease with US approval

AstraZeneca hails progress on chronic kidney disease with US approval

3 May 21 07:58

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

30 Apr 21 17:01

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.